Abinet Aklilu, MD, MPH
Postdoctoral Fellow
Research & Publications
Biography
News
Coauthors
Selected Publications
- Personalised recommendations for hospitalised patients with Acute Kidney Injury using a Kidney Action Team (KAT-AKI): protocol and early data of a randomised controlled trialAklilu A, O’Connor K, Martin M, Yamamoto Y, Coronel-Moreno C, Shvets K, Jones C, Kadhim B, Corona-Villalobos C, Baker M, Tan J, Freeman N, Groener M, Menez S, Brown D, Culli S, Lindsley J, Orias M, Parikh C, Smith A, Sundararajan A, Wilson F. Personalised recommendations for hospitalised patients with Acute Kidney Injury using a Kidney Action Team (KAT-AKI): protocol and early data of a randomised controlled trial. BMJ Open 2023, 13: e071968. PMID: 37068906, PMCID: PMC10111926, DOI: 10.1136/bmjopen-2023-071968.
- Renal Considerations in Critically Ill Hematopoietic Stem Cell Transplant PatientsAklilu A, Renaghan A. Renal Considerations in Critically Ill Hematopoietic Stem Cell Transplant Patients. 2023, 351-364. DOI: 10.1007/978-3-031-28797-8_27.
- A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomesWilson F, Yamamoto Y, Martin M, Coronel-Moreno C, Li F, Cheng C, Aklilu A, Ghazi L, Greenberg J, Latham S, Melchinger H, Mansour S, Moledina D, Parikh C, Partridge C, Testani J, Ugwuowo U. A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes. Nature Communications 2023, 14: 2826. PMID: 37198160, PMCID: PMC10192367, DOI: 10.1038/s41467-023-38532-3.
- Chemotherapy-Associated Thrombotic MicroangiopathyAklilu A, Shirali A. Chemotherapy-Associated Thrombotic Microangiopathy. Kidney360 2023, 4: 409-422. PMID: 36706238, PMCID: PMC10103319, DOI: 10.34067/kid.0000000000000061.
- Diagnosis of Chronic Kidney Disease and Assessing Glomerular Filtration RateAklilu A. Diagnosis of Chronic Kidney Disease and Assessing Glomerular Filtration Rate. Medical Clinics Of North America 2023, 107: 641-658. PMID: 37258004, DOI: 10.1016/j.mcna.2023.03.001.
- Diversity in Studies Developing Kidney Function Estimating Equations: Improving Representation, Interpretation, and Utility of Clinical ResearchAlvarado F, Aklilu A, Powe N, Vart P, Delgado C. Diversity in Studies Developing Kidney Function Estimating Equations: Improving Representation, Interpretation, and Utility of Clinical Research. American Journal Of Kidney Diseases 2022, 81: 1-6. PMID: 35842013, DOI: 10.1053/j.ajkd.2022.05.014.
- The removal of race from kidney function estimation: Key points for primary providersAklilu A, Delgado C. The removal of race from kidney function estimation: Key points for primary providers. Journal Of The National Medical Association 2022, 114: s25-s33. PMID: 35595580, DOI: 10.1016/j.jnma.2022.05.008.
- Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19Nugent J, Aklilu A, Yamamoto Y, Simonov M, Li F, Biswas A, Ghazi L, Greenberg J, Mansour S, Moledina D, Wilson FP. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19. JAMA Network Open 2021, 4: e211095. PMID: 33688965, PMCID: PMC7948062, DOI: 10.1001/jamanetworkopen.2021.1095.
- Dialysis Patient Experiences During the COVID-19 Pandemic: A Survey StudyNoce E, Brereton L, Zorzanello M, Aklilu A, Anders E, Bernal M, Sundararajan A, Dahl N, Kodali R, Patel D. Dialysis Patient Experiences During the COVID-19 Pandemic: A Survey Study. Kidney Medicine 2023, 5: 100673. PMID: 37305377, PMCID: PMC10186967, DOI: 10.1016/j.xkme.2023.100673.
- Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by AKIAklilu A, Kumar S, Yamamoto Y, Moledina D, Sinha F, Testani J, Wilson F. Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by AKI. Kidney360 2023, 4: 1371-1381. PMID: 37644648, PMCID: PMC10615381, DOI: 10.34067/kid.0000000000000250.
- A Glimpse into an Editorial Training Program: From the Kidney360 Editorial Program TraineesFisher M, Aklilu A, Ng M, Spires D, Vieira M. A Glimpse into an Editorial Training Program: From the Kidney360 Editorial Program Trainees. Kidney360 2023, 5: 117-120. PMCID: PMC10833592, DOI: 10.34067/kid.0000000000000311.
- The VUS Challenge in Cystic Kidney Disease: A Case-Based ReviewAklilu A, Gulati A, Kolber K, Yang H, Harris P, Dahl N. The VUS Challenge in Cystic Kidney Disease: A Case-Based Review. Kidney360 2023, 5: 152-159. PMID: 37962562, PMCID: PMC10833605, DOI: 10.34067/kid.0000000000000298.
- Abstract 13604: Sodium-Glucose-Cotransporter-2 Inhibitor (SGLT2i) Exposure in the Immediate Post-Acute Kidney Injury Period in Patients Hospitalized With Acute Heart Failure is Associated With Improved OutcomesKumar S, Aklilu A, Ahmad T, Wilson F. Abstract 13604: Sodium-Glucose-Cotransporter-2 Inhibitor (SGLT2i) Exposure in the Immediate Post-Acute Kidney Injury Period in Patients Hospitalized With Acute Heart Failure is Associated With Improved Outcomes. Circulation 2022, 146: a13604-a13604. DOI: 10.1161/circ.146.suppl_1.13604.
- Infiltrative Disease of the TubulointerstitiumAklilu A, Luciano R. Infiltrative Disease of the Tubulointerstitium. 2022, 231-241. DOI: 10.1007/978-3-030-93438-5_18.
- Eosinophilia and Skin Rash in a Patient with Uncontrolled Hypertension and AKIAklilu A. Eosinophilia and Skin Rash in a Patient with Uncontrolled Hypertension and AKI. Kidney360 2021, 2: 2038-2039. PMID: 35419544, PMCID: PMC8986042, DOI: 10.34067/kid.0004422021.
- A unique case of purple urine: A case report and literature review.Aklilu AM, Avigan ZM, Brewster UC. A unique case of purple urine: A case report and literature review. Clinical Nephrology 2021, 95: 273-277. PMID: 33605870, DOI: 10.5414/cn110272.